By Associate Professor Ewan Kerr Alexander Millar

Conference Abstracts

Hepburn K; Millar E; Kelly J; Katz I, 2018, 'ANTIBODY NEGATIVE ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE', in NEPHROLOGY, WILEY, Vol. 23, pp. 79 - 79, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000443138700255&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Pang J-M; Chand A; Knower K; Takano E; Byrne D; Sprenkeler E; Molania R; Millar E; Lee S; O'Toole S; Clyne C; Dobrovic A; Fox S, 2015, 'Abstract 2962: LRH-1 expression in breast cancer tissue and its association with phenotype and DNA methylation', in Cancer Research, American Association for Cancer Research (AACR), Vol. 75, pp. 2962 - 2962, http://dx.doi.org/10.1158/1538-7445.am2015-2962

Gallego-Ortega D; Ledger A; Roden D; Cho C; Allerdice SL; Lee HJ; Valdes-Mora F; Lee B; Kaplan W; Salomon R; Piggin C; Rabinovich B; Millar E; Chtanova T; Swarbrick A; Clark S; Ormandy C, 2015, 'The ETS transcription factor ELF5 drives metastasis via angiogenesis and recruitment of Gr-1+ CD11b+ myeloid derived suppressor cells in luminal breast cancer', in Clinical and Experimental Metastasis, Springer Verlag (Germany), Vol. 32, pp. 203 - 203, presented at MRS 15th International biennial congress of the metastasis research society

Nair R; Teo WS; Ye S; McFarland A; Harvey K; Roden D; Junankar S; Baker L; Yang J; Fluke N; Millar E; Mellick A; Naylor M; Ormandy C; Lakhani S; O'Toole S; Swarbrick A, 2015, 'The Inhibitor of Differentiation proteins mediate tumour-initiating properties and metastasis in breast cancer', in CLINICAL & EXPERIMENTAL METASTASIS, SPRINGER, Vol. 32, pp. 224 - 224, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000351601900129&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Graham PH; Browne L; Capp A; Delaney G; Fox C; Millar EK; Nasser E; Papadatos G, 2015, 'Predictors of responses and sexual function for women in the St George breast boost randomized trial (StGBBT)', in The Breast, Elsevier, Vol. 24, pp. 304, http://dx.doi.org/10.1016/j.breast.2015.02.011

Millar EKA; Coates AS; O'Toole S; Selinger C; Musgrove EA; Yan M; Viale G; Regan MM; Price KN; Sun Z; Castiglione MM; Colleoni M; Gelber RD; Goldhirsch A; Sutherland RL, 2012, 'Intrinsic subtype and its clinical significance in early node-negative breast cancer: Results from two randomized trials of adjuvant chemoendocrine therapy.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, IL, Chicago, Vol. 30, presented at 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 01 June 2012 - 06 June 2012, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000318009800179&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

O'Toole S; Machalek D; Shearer R; Millar E; Nair R; Martelotto L; McLeod D; Cooper C; Ru Qiu M; Sutherland R; Watkins D; Swarbrick A, 2010, 'Abstract S6-8: Hedgehog Ligand Overexpression Predicts Poor Outcome in Breast Cancer and Is a Potential Therapeutic Target for Metastatic Disease', in Cancer Research, American Association for Cancer Research (AACR), Vol. 70, pp. s6-8-s6-8, http://dx.doi.org/10.1158/0008-5472.sabcs10-s6-8

Lopez-Knowles E; O'Toole SA; McNeil CM; Millar EKA; Qiu MR; Crea P; Daly RJ; Musgrove EA; Sutherland RL, 2009, 'PI3K Pathway Activation in Breast Cancer Is Associated with the Basal-Like Phenotype and Cancer-Specific Mortality', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, TX, San Antonio, Vol. 69, pp. 632S - 632S, presented at 32nd Annual San Antonio Breast Cancer Symposium, TX, San Antonio, 09 December 2009 - 13 December 2009

Back to profile page